Ladislav Valkovic1,2, Albrecht I Schmid1,3, Lucian AB Purvis1, Jane Ellis1, Matthew D Robson1, Stefan Neubauer1, and Christopher T Rodgers1,4
1Oxford Centre for Clinical MR Research (OCMR), RDM Cardiovascular Medicine, University of Oxford, Oxford, United Kingdom, 2Department of Imaging Methods, Institute of Measurement Science, Slovak Academy of Sceinces, Bratislava, Slovakia, 3High-Field MR Centre, Center for Medical Physics and Biomedical Engineering, Medical University of Vienna, Vienna, Austria, 4The Wolfson Brain Imaging Centre, University of Cambridge, Cambridge, United Kingdom
Synopsis
Determination of human cardiac Pi using 31P-MRS
is challenging as the resonance frequency of Pi is concealed by a close
resonating 2,3-DPG signal originating from blood. Long TR acquisition using
adiabatic excitation at 7T can compensate for the rapid blood signal
replacement in partially-saturated short TR scans. In order to quantify Pi
concentration in vivo, knowledge about longitudinal relaxation of Pi is still
required. We have measured the T1 of Pi in 4 healthy volunteers at
7T using dual-TR method and used this value to quantify cardiac Pi concentration
in 8 healthy volunteers.
Introduction
Phosphorus
MR spectroscopy (31P-MRS) is a valuable technique for non-invasive
measurement of high-energy metabolites, e.g. adenosine triphosphate (ATP) and
phosphocreatine (PCr), that allows assessment of tissue energy metabolism in
vivo. Interest in 31P-MRS is great in cardiovascular medicine, as
the PCr/ATP concentration ratio in the heart changes in most major disease
states1,2. Nevertheless, the full potential of cardiac 31P-MRS
is not robustly accessible as the quantification of cardiac inorganic phosphate
(Pi), important for ATP synthesis, is hindered by the dominant signal of 2,3-diphosphoglycerate
(2,3-DPG), originating from the blood. We have recently demonstrated the ability
to detect cardiac Pi in vivo using long TR and adiabatic excitation at 7T and
use it to calculate cardiac pH, which is important as acidosis can limit
heart’s ability to pump blood in disease3. However, even with acquisitions using relatively long TR,
partial saturation of Pi signal cannot be fully excluded due to generally long
T1 times of phosphorus metabolites4,5, making
straightforward quantification without T1 correction unfeasible.
Therefore, our aim was to determine the T1
of Pi in human heart at 7T using adiabatic excitation with a dual TR technique6.
We also report Pi concentration, quantified using our measured T1,
relative to ATP and PCr in 8 healthy volunteers.Materials and Methods
All
measurements were performed on a 7T MR system (Siemens) equipped with a custom dual-tuned
RF-coil, comprising a quadrature 31P coil (two 15cm loops, with
overlap decoupling)7 and a single 1H loop (10cm in
diameter) for localization.
First,
four healthy subjects (3M/1F) were recruited for determination of the T1
of cardiac Pi in compliance with local regulations. Two 3D UTE-CSI8
acquisitions (matrix size 8x16x8 and FOV of 240x240x200mm3) were
made, one with the shortest possible and one matching our previous study3.
The SAR limits for the narrow-banded AHP pulse9 we used did not
allow TR< 3s. Our chosen TRs were therefore: TR1 = 3s
and TR2 = 6s. As the AHP pulse has a relatively narrow
bandwidth at the achievable B1+, the excitation was
centred at +600Hz from the PCr resonance frequency. Simulations of the Bloch Equations
were used to estimate the expected errors in calculated T1 for resonance
offsets range from -180Hz to 180Hz from centre frequency, for the possible T1s
ranging from 1s to 10s.
Second,
data from eight healthy volunteers (7M/1F) were used to quantify the Pi/ATP and
Pi/PCr ratios. We used our previously reported protocol for cardiac 31P-MRS
using interleaved AHP excitation at 7T9. In short, the AHP
excitation is interleaved to excite the PCr and ATP region in odd acquisitions and
the Pi and DPG region in even acquisitions. The effective TR was 6s and other
parameters match the T1 measurements. Six septal voxels were fitted in
all in vivo data using a Matlab implementation of AMARES10 and corrected for T1
relaxation using the measured values for Pi and literature values for ATP and
PCr5. The T1 of Pi in chest muscles (again taking six
voxels) was evaluated for comparison.Results and Discussion
Figure 1 depicts the simulated off-resonance
error in T1 estimation using the AHP pulse for the lowest B1+
expected in the heart, i.e. 16μT7.
This shows that even in the worst case, the potential error is below 20% for a
range of frequencies ±30Hz, i.e. 0.25ppm. The asymmetry of the AHP pulse starts
to play a role for larger frequency offsets; the smoother side of the pulse,
which faces PCr here, gives smaller errors.
Figure 2 shows 31P-MRS spectra
from the chest muscles and septum of one volunteer acquired at TR1
and TR2. The inter-subject mean T1 of Pi measured in
skeletal muscles was 6.3±0.7s and in human heart it was 5.1±0.2s. The chest
muscle T1 value is in good agreement with the measurements in calf
muscle4 at 7T and the measured T1 of cardiac Pi follows
the trend of slightly shorter 31P T1s in the human heart compared
to skeletal muscle5. Values for each individual subject are given in
Table 1.
Table 2 shows the Pi ratios to ATP and PCr,
together with the PCr/ATP ratio, for each individual subject. The inter-subject
mean Pi/PCr ratio was 0.15±0.02, which is in good agreement with literature
values of 0.12±0.03 determined at 1.5T using proton decoupling to separate Pi
from 2,3-DPG signals (success rate in healthy volunteers was ~50% in these
studies)11,12.Conclusion
This study provides a longitudinal relaxation
time of cardiac Pi at 7T measured by the dual-TR technique with adiabatic
excitation. The measured T1 enables us to report the
saturation-corrected Pi/PCr ratio for the first time in the human heart at 7T.Acknowledgements
We
acknowledge financial support from the Sir Henry Dale Fellowship awarded
jointly by the Wellcome Trust and the Royal Society (098436/Z/12/Z), and Slovak
Grant Agencies VEGA (2/0001/17) and APVV (15-0029).References
1.
Bottomley P, et al. Radiology 1987;165:703-7
2.
Neubauer S, et al. Circulation 1992;86:1810-8
3.
Valkovič L,
et al. Proc ISMRM 2017;2933
4.
Bogner W, et al. Magn Reson Med 2009;62:574-82
5.
Rodgers CT, et al. Magn Reson Med 2014;72:304-15
6.
El-Sharkawy AM, et al. Magn
Reson Med 2009;61:785-95
7.
Schaller B, et al. Proc. ISMRM 2016;24:4006
8.
Robson MD, et al. Magn Reson Med 2005; 53:267-74.
9.
Yarnykh VL, Magn Reson Med 2007;57:192-200
10. Purvis LAB, et al. PLoS ONE
2017;12:e0185356
11. Luyten PR, et al. NMR Biomed
1989;1:177-83
12. Sieverding L, et al. Am J
Cardiol 1997;80:A34-40